REFERENCES
1. Duley L. The Global Impact of Pre-eclampsia and Eclampsia. Semin
Perinatol. 2009;33(3):130–7.
2. Say L, Chou D, Gemmill A, Tunçalp Ö, Moller AB, Daniels J, et al.
Global causes of maternal death: A WHO systematic analysis. Lancet Glob
Health. 2014;2(6):323–33.
3. Gardosi J, Kady SM, McGeown P, Francis A TA. Classification of
stillbirth by relevant condition at death (ReCoDe): population based
cohort study. BMJ. 2005;331(1113–1117).
4. Iams JD, Goldenberg RL, Mercer BM, Moawad A, Thom E, Meis PJ, et al.
The Preterm Prediction Study: recurrence risk of spontaneous preterm
birth. National Institute of Child Health and Human Development
Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol.
1998;178(5):1035–40.
5. Lisonkova S, Joseph KS. Incidence of preeclampsia: Risk factors and
outcomes associated with early-versus late-onset disease. Am J Obstet
Gynecol. 2013;209(6):544.e1-544.e12.
6. Weitzner O, Yagur Y, Weissbach T, Man El G, Biron-Shental T.
Preeclampsia: risk factors and neonatal outcomes associated with early-
versus late-onset diseases. J Matern Fetal Neonatal Med. 2018;6:1–5.
7. Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R.
Pre-eclampsia. The Lancet. 2010;376(9741):631–44.
8. von Dadelszen P, Menzies JM, Payne B, Magee LA. Predicting Adverse
Outcomes in Women with Severe Pre-eclampsia. Semin Perinatol.
2009;33(3):152–7.
9. Thangaratinam S, Allotey J, Marlin N, Dodds J, Cheong-See F, von
Dadelszen P, et al. Prediction of complications in early-onset
pre-eclampsia (PREP): development and external multinational validation
of prognostic models. BMC Med. 2017;15(1):1–11.
10. Alanwar A, El Nour AA, El Mandooh M, Abdelazim IA, Abbas L, Abbas
AM, et al. Prognostic accuracy of cerebroplacental ratio for adverse
perinatal outcomes in pregnancies complicated with severe pre-eclampsia;
a prospective cohort study. Pregnancy Hypertens. 2018;14(April):86–9.
11. El-Demiry NM, Maged AM, Gaafar HM, ElAnwary S, Shaltout A, Ibrahim
S, et al. The value of fetal Doppler indices as predictors of perinatal
outcome in women with preeclampsia with severe features. Hypertens
Pregnancy. 2020;39(2):95–102.
12. Gómez-Arriaga PI, Herraiz I, López-Jiménez EA, Escribano D, Denk B,
Galindo A. Uterine artery Doppler and sFlt-1/PlGF ratio: Prognostic
value in early-onset pre-eclampsia. Ultrasound Obstet Gynecol.
2014;43(5):525–32.
13. Rani S, Huria A, Kaur R. Prediction of perinatal outcome in
preeclampsia using middle cerebral artery and umbilical artery
pulsatility and resistance indices. Hypertens Pregnancy.
2016;35(2):210–6.
14. Stubert J, Ullmann S, Dieterich M, Diedrich D, Reimer T. Clinical
differences between early- and late-onset severe preeclampsia and
analysis of predictors for perinatal outcome. J Perinat Med.
2014;42(5):617–27.
15. Lees C, Marlow N, Arabin B, Bilardo CM, Brezinka C, Derks JB.
Perinatal morbidity and mortality in early-onset fetal growth
restriction : cohort outcomes of the trial of randomized umbilical and
fetal flow in Europe ( TRUFFLE ). Ultrasound Obstet Gynecol.
2013;(July):400–8.
16. Wang A, Rana S, Karumanchi SA. Preeclampsia: The Role of Angiogenic
Factors in Its Pathogenesis. Physiology. 2009;24(3):147–58.
17. Karumanchi SA. Angiogenic factors in preeclampsia: From diagnosis to
therapy. Hypertension. 2016;67(6):1072–9.
18. Zeisler H, Llurba E, Chantraine F, Vatish M, Staff AC, Sennström M,
et al. Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected
Preeclampsia. N Engl J Med. 2016;374(1):13–22.
19. Chappell L, Duckworth S, Seed P, Griffin M, Myers J, Mackillop L, et
al. Diagnostic Accuracy of Placental Growth Factor in Women With
Suspected Preeclampsia: A Prospective Multicenter Study. Circulation.
2013;128(19):2121–31.
20. Rana S, Powe CE, Salahuddin S, Verlohren S, Perschel FH, Levine RJ,
et al. Angiogenic factors and the risk of adverse outcomes in women with
suspected preeclampsia. Circulation. 2012;125(7):911–9.
21. Verlohren S, Herraiz I, Lapaire O, Schlembach D, Moertl M, Zeisler
H, et al. The sFlt-1/PlGF ratio in different types of hypertensive
pregnancy disorders and its prognostic potential in preeclamptic
patients. Am J Obstet Gynecol. 2012;206(1):58.e1-58.e8.
22. Tranquilli AL, Dekker G, Magee L, Roberts J, Sibai BM, Steyn W, et
al. The classification, diagnosis and management of the hypertensive
disorders of pregnancy: A revised statement from the ISSHP. Pregnancy
Hypertens. 2014;4(2):97–104.
23. American College of Obstetricians and Gynecologists; Task Force on
Hypertension in pregnancy. Hypertension in Pregnancy. Obstet Gynecol.
2013;122(5):1122–31.
24. Robinson H, Fleming J. A critical evaluation of sonar ‘crown-rump
length’ measurements. Br J Obstet Gynaecol. 1975;82:702–10.
25. Gordijn SJ, Beune IM, Thilaganathan B, Papageorghiou A, Baschat AA,
Baker PN, et al. Consensus definition of fetal growth restriction: a
Delphi procedure. Ultrasound Obstet Gynecol. 2016;48(3):333–9.
26. Thangaratinam S, Allotey J, Marlin N, Mol BW, Von Dadelszen P,
Ganzevoort W, et al. Development and validation of Prediction models for
Risks of complications in Early-onset Pre-eclampsia (PREP): a
prospective cohort study. Health Technol Assess. 2017;21(18).
27. Hadlock FP, Harrist RB, Sharman RS, Deter RL, Park SK. Estimation of
fetal weight with the use of head, body, and femur measurements–a
prospective study. Am J Obstet Gynecol. 1985;151(3):333–7.
28. Arduini D, Rizzo G. Normal values of Pulsatility Index from fetal
vessels: a cross-sectional study on 1556 healthy fetuses. J Perinat Med.
1990;18(3):165–72.
29. Gómez O, Figueras F, Fernández S, Bennasar M, Martínez JM, Puerto B,
et al. Reference ranges for uterine artery mean pulsatility index at
11-41 weeks of gestation. Ultrasound Obstet Gynecol. 2008
Aug;32(2):128–32.
30. ACOG Practice Bulletin No202: Gestational Hypertension and
Preeclampsia. Obstet Gynecol. 2020;135(6):1492–5.
31. Macones GA, Hankins GD V, Spong CY, Hauth J, Moore T. The 2008
National Institute of Child Health and Human Development workshop report
on electronic fetal monitoring: update on definitions, interpretation,
and research guidelines. Obstet Gynecol. 2008 Sep;112(3):661–6.
32. Figueras F, Gratacos E. An integrated approach to fetal growth
restriction. Best Pract Res Clin Obstet Gynaecol. 2017;38:48–58.
33. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the Areas under
Two or More Correlated Receiver Operating Characteristic Curves: A
Nonparametric Approach. Biometrics. 1988;44(3):837–45.
34. Orabona R, Gerosa V, Gregorini ME, Pagani G, Prefumo F, Valcamonico
A, et al. The prognostic role of various indices and ratios of Doppler
velocimetry in patients with pre-eclampsia. Clin Exp Hypertens.
2015;37(1):57–62.
35. Duhig KE, Myers J, Seed PT, Sparkes J, Lowe J, Hunter RM, et al.
Placental growth factor testing to assess women with suspected
pre-eclampsia: a multicentre, pragmatic, stepped-wedge
cluster-randomised controlled trial. The Lancet. 2019
May;393(10183):1807–18.
36. Pinheiro CC, Rayol P, Gozzani L, dos Reis LM, Zampieri G, Dias CB,
et al. The relationship of angiogenic factors to maternal and neonatal
manifestations of early-onset and late-onset preeclampsia. Prenat Diagn.
2014;34(11):1084–92.
37. Simón E, Permuy C, Sacristán L, Zamoro-Lorenci MJ, Villalaín C,
Galindo A, et al. sFlt-1/PlGF ratio for the prediction of delivery
within 48 hours and adverse outcomes in expectantly managed early-onset
preeclampsia. Pregnancy Hypertens. 2020;22(July):17–23.
38. Dröge LA, Perschel FH, Stütz N, Gafron A, Frank L, Busjahn A, et al.
Prediction of Preeclampsia-Related Adverse Outcomes with the sFlt-1
(Soluble fms-Like Tyrosine Kinase 1)/PlGF (Placental Growth
Factor)-Ratio in the Clinical Routine: A Real-World Study. Hypertension.
2021;1(February):461–71.
39. Duffy J, Cairns AE, Richards-Doran D, van ’t Hooft J, Gale C, Brown
M, et al. A core outcome set for pre-eclampsia research: an
international consensus development study. BJOG Int J Obstet Gynaecol.
2020 Nov;127(12):1516–26.